(Q73168338)
Statements
Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study Group (English)
J M Buzelin
S Roth
C Geffriaud-Ricouard
M C Delauche-Cavallier
scientific article published on 01 January 1997